Amarin Corporation PLC (NASDAQ:AMRN)

1.13
Data as of Dec 19
 +0.08 / +7.62%
Today’s Change
0.78
Today|||52-Week Range
2.75
-42.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$196.8M

Company Description

Amarin Corp. Plc is a biopharmaceutical company, which is focused on the commercialization and development of therapeutics to improve cardiovascular health. The company's lead product Vascepa capsules is an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. The company is also developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol. Amarin was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Contact Information

Amarin Corp. Plc
2 Pembroke House
Dublin Dublin 2
P:(531) 669-9020
Investor Relations:
(908) 719-1315

Employees

Shareholders

Mutual fund holders8.96%
Individual stakeholders4.89%
Other institutional27.45%

Top Executives

John F. TheroPresident, Chief Executive Officer & Director
Michael FarrellChief Financial & Accounting Officer
Steven B. KetchumSenior VP, President-Research & Development
Paresh SoniSenior Vice President & Head-Development
Joseph T. KennedySecretary, Chief Compliance Officer & Senior VP

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.